Biolife Solutions Stock Investor Sentiment
| BLFS Stock | USD 25.33 0.00 0.00% |
Slightly above 56% of BioLife Solutions' investor base is looking to short. The analysis of overall sentiment of trading BioLife Solutions stock suggests that many investors are alarmed at this time. BioLife Solutions' investing sentiment can be driven by a variety of factors including economic data, BioLife Solutions' earnings reports, geopolitical events, and overall market trends.
Comfort Level 44
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use BioLife Solutions' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward BioLife Solutions.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
BioLife Historical Sentiment
Although BioLife Solutions' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding BioLife, such as negative comments on social media and news outlets, may cause fear in the market and push BioLife Solutions' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of BioLife.
BioLife Solutions Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards BioLife Solutions can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BioLife Solutions Historical Investor Sentiment
Investor biases related to BioLife Solutions' public news can be used to forecast risks associated with an investment in BioLife. The trend in average sentiment can be used to explain how an investor holding BioLife can time the market purely based on public headlines and social activities around BioLife Solutions. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
BioLife Solutions' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for BioLife Solutions and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average BioLife Solutions news discussions. The higher the estimate score, the more favorable the investor's outlook on BioLife Solutions.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of BioLife Solutions' Stock prices. Below is the latest headlines and news related to BioLife Solutions Stock. Current markets are strongly bullish. About 81% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about BioLife Solutions that are available to investors today. This information is accessible both publicly - through BioLife Solutions' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of BioLife-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of BioLife Solutions news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioLife Solutions relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioLife Solutions' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioLife Solutions alpha.
BioLife Largest EPS Surprises
Earnings surprises can significantly impact BioLife Solutions' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-05-13 | 2021-03-31 | -0.04 | -0.03 | 0.01 | 25 | ||
2020-05-14 | 2020-03-31 | -0.02 | -0.01 | 0.01 | 50 | ||
2019-05-09 | 2019-03-31 | 0.04 | 0.03 | -0.01 | 25 | ||
2019-03-14 | 2018-12-31 | 0.05 | 0.04 | -0.01 | 20 | ||
2018-11-08 | 2018-09-30 | 0.04 | 0.05 | 0.01 | 25 | ||
2018-08-09 | 2018-06-30 | 0.04 | 0.05 | 0.01 | 25 |
There is far too much social signal, news, headlines, and media speculation about BioLife Solutions that are available to investors today. This information is accessible both publicly - through BioLife Solutions' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of BioLife-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of BioLife Solutions news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BioLife Solutions relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BioLife Solutions' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BioLife Solutions alpha.
BioLife Solutions Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Disposition of 275 shares by Sean Werner of BioLife Solutions at 27.82 subject to Rule 16b-3 | 10/20/2025 |
2 | Disposition of 37795 shares by De Greef Roderick of BioLife Solutions at 27.3 subject to Rule 16b-3 | 10/22/2025 |
3 | BioLife Solutions Evaluating Valuation After Strategic Refocus and Robust Revenue Growth in Cell Gene Therapy | 10/24/2025 |
4 | Disposition of 35417 shares by De Greef Roderick of BioLife Solutions at 26.15 subject to Rule 16b-3 | 11/11/2025 |
5 | Disposition of 2000 shares by Duross Amy of BioLife Solutions at 27.0 subject to Rule 16b-3 | 11/26/2025 |
6 | Opening of New Biopreservation Center Might Change the Case for Investing in BioLife Solutions | 12/01/2025 |
7 | Disposition of 30000 shares by Troy Wichterman of BioLife Solutions at 25.72 subject to Rule 16b-3 | 12/04/2025 |
8 | Analyzing BioLife Solutions Glucose Health | 12/10/2025 |
9 | Disposition of 2000 shares by Duross Amy of BioLife Solutions at 24.6 subject to Rule 16b-3 | 12/15/2025 |
10 | BioLife Solutions Director Amy Duross Sells 2,000 Shares | 12/18/2025 |
11 | Disposition of 217 shares by Aebersold Sarah of BioLife Solutions at 26.74 subject to Rule 16b-3 | 12/24/2025 |
12 | BioLife Solutions Maintains Buy Rating, Price Target St - GuruFocus | 12/29/2025 |
13 | Disposition of 1000000 shares by Casdin Partners Master Fund, L.p. of BioLife Solutions at 23.8 subject to Rule 16b-3 | 12/30/2025 |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.